167 related articles for article (PubMed ID: 15150077)
1. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.
Rivailler P; Carville A; Kaur A; Rao P; Quink C; Kutok JL; Westmoreland S; Klumpp S; Simon M; Aster JC; Wang F
Blood; 2004 Sep; 104(5):1482-9. PubMed ID: 15150077
[TBL] [Abstract][Full Text] [Related]
2. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.
Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F
J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868
[TBL] [Abstract][Full Text] [Related]
3. Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.
Sashihara J; Hoshino Y; Bowman JJ; Krogmann T; Burbelo PD; Coffield VM; Kamrud K; Cohen JI
PLoS Pathog; 2011 Oct; 7(10):e1002308. PubMed ID: 22028652
[TBL] [Abstract][Full Text] [Related]
4. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.
Ohashi M; Fogg MH; Orlova N; Quink C; Wang F
PLoS Pathog; 2012 Dec; 8(12):e1003095. PubMed ID: 23300447
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.
Rao P; Jiang H; Wang F
J Clin Microbiol; 2000 Sep; 38(9):3219-25. PubMed ID: 10970361
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model.
Mühe J; Aye PP; Quink C; Eng JY; Engelman K; Reimann KA; Wang F
Cell Rep Med; 2021 Jul; 2(7):100352. PubMed ID: 34337567
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.
Orlova N; Fogg MH; Carville A; Wang F
Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064
[TBL] [Abstract][Full Text] [Related]
8. Non-human Primate Lymphocryptoviruses: Past, Present, and Future.
Mühe J; Wang F
Curr Top Microbiol Immunol; 2015; 391():385-405. PubMed ID: 26428382
[TBL] [Abstract][Full Text] [Related]
9. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus.
Cho YG; Gordadze AV; Ling PD; Wang F
J Virol; 1999 Nov; 73(11):9206-12. PubMed ID: 10516028
[TBL] [Abstract][Full Text] [Related]
10. Experimental co-transmission of Simian Immunodeficiency Virus (SIV) and the macaque homologs of the Kaposi Sarcoma-Associated Herpesvirus (KSHV) and Epstein-Barr Virus (EBV).
Bruce AG; Barcy S; Staheli J; Bielefeldt-Ohmann H; Ikoma M; Howard K; Rose TM
PLoS One; 2018; 13(11):e0205632. PubMed ID: 30444879
[TBL] [Abstract][Full Text] [Related]
11. Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.
Marr-Belvin AK; Carville AK; Fahey MA; Boisvert K; Klumpp SA; Ohashi M; Wang F; O'Neil SP; Westmoreland SV
Vet Pathol; 2008 Nov; 45(6):914-21. PubMed ID: 18984796
[TBL] [Abstract][Full Text] [Related]
12. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
Fogg MH; Kaur A; Cho YG; Wang F
J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
Herrman M; Mühe J; Quink C; Wang F
J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839
[TBL] [Abstract][Full Text] [Related]
14. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.
Moghaddam A; Koch J; Annis B; Wang F
J Virol; 1998 Apr; 72(4):3205-12. PubMed ID: 9525646
[TBL] [Abstract][Full Text] [Related]
15. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
16. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
Jiang H; Cho YG; Wang F
J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
[TBL] [Abstract][Full Text] [Related]
17. Summary of roundtable discussion meeting: non-human primates to assess risk for EBV-related lymphomas in humans.
Kawabata T; Weaver J; Thomas D; Rowe M; Wang F; Kamperschroer C; Haggerty H
J Immunotoxicol; 2012; 9(1):121-7. PubMed ID: 22136193
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.
Leskowitz R; Fogg MH; Zhou XY; Kaur A; Silveira EL; Villinger F; Lieberman PM; Wang F; Ertl HC
J Virol; 2014 May; 88(9):4721-35. PubMed ID: 24522914
[TBL] [Abstract][Full Text] [Related]
19. Nonhuman primate models for Epstein-Barr virus infection.
Wang F
Curr Opin Virol; 2013 Jun; 3(3):233-7. PubMed ID: 23562212
[TBL] [Abstract][Full Text] [Related]
20. Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.
Ohashi M; Orlova N; Quink C; Wang F
J Virol; 2011 Feb; 85(3):1330-9. PubMed ID: 21084476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
